Holen Sie sich die Stockscreener-App
0.4028
7.27%
-0.0316
Schlusskurs vom Vortag:
$0.4344
Offen:
$0.431
24-Stunden-Volumen:
320.84K
Relative Volume:
0.27
Marktkapitalisierung:
$5.36M
Einnahmen:
$72,100
Nettoeinkommen (Verlust:
$-3.60M
KGV:
-0.3385
EPS:
-1.19
Netto-Cashflow:
$-3.37M
1W Leistung:
-11.36%
1M Leistung:
-2.52%
6M Leistung:
-31.43%
1J Leistung:
-51.77%
1-Tages-Spanne:
$0.4028
$0.4373
1-Wochen-Bereich:
$0.4028
$0.4599
52-Wochen-Spanne:
$0.3601
$3.3699
Silo Pharma Inc Stock (SILO) Company Profile
Firmenname
Silo Pharma Inc
Sektor
Branche
Telefon
(718) 400-9031
Adresse
677 N. WASHINGTON BLVD, SARASOTA
Vergleichen Sie SILO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.17 | 303.77M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.04 | 221.34M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.67 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.76 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
What drives Silo Pharma Inc stock priceGrowth vs. Value Investing & Download Our Free Trading Blueprint - earlytimes.in
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.8% – What’s Next? - Defense World
How Silo Pharma Inc. stock performs during Fed tightening cycles2025 Top Decliners & Community Verified Trade Alerts - Newser
SILO Pharma (SILO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Silo Pharma Inc. stock remains resilientJuly 2025 Spike Watch & Safe Capital Preservation Plans - BỘ NỘI VỤ
Is Silo Pharma Inc a good long term investmentContrarian Investment Ideas & Free Record-Breaking Gains - earlytimes.in
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com India
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Is Silo Pharma Inc. stock attractive for long term wealth buildingEntry Point & Long-Term Safe Return Strategies - newser.com
Is now a turning point for Silo Pharma Inc.July 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission By Investing.com - Investing.com Nigeria
Evaluating Silo Pharma Inc. with trendline analysisMarket Rally & Weekly Stock Performance Updates - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission - Investing.com
Silo Pharma partners with Allucent to support planned FDA Investigational New Drug application for SPC-15 as a therapeutic for PTSD - MarketScreener
Silo Pharma Partners With Allucent To Support Planned FDA Investigational New Drug Application For Spc-15 As A Therapeutic For Ptsd - TradingView
Silo Pharma Partners with Allucent to Support Planned FDA - GlobeNewswire
Silo Pharma (Nasdaq: SILO) taps Allucent to advance SPC-15 PTSD intranasal IND prep - Stock Titan
Can Silo Pharma Inc. stock deliver strong Q4 earningsNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Will Silo Pharma Inc. rebound enough to break evenExit Point & Weekly Watchlist for Hot Stocks - newser.com
Combining price and volume data for Silo Pharma Inc.July 2025 Trends & Consistent Profit Trade Alerts - newser.com
[10-Q] Silo Pharma, Inc. Quarterly Earnings Report | SILO SEC FilingForm 10-Q - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
What analysts say about Silo Pharma Inc stockEx-Dividend Date Alerts & Maximize ROI With Proven Growth Stocks - earlytimes.in
How strong is Silo Pharma Inc. stock revenue growthJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Silo Pharma announces pricing of $2 million public offering - MSN
Is Silo Pharma Inc. showing signs of accumulationEarnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
Finanzdaten der Silo Pharma Inc-Aktie (SILO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Silo Pharma Inc-Aktie (SILO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
| Weisblum Eric | Chief Executive Officer |
May 27 '25 |
Buy |
0.43 |
10,000 |
4,329 |
197,932 |
0.36%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):